A genome-wide susceptibility assay was used to identify specific CpxR-dependent genes
that facilitate Escherichia coli resistance to a model cationic antimicrobial peptide …

Of the six putative small multidrug resistance (SMR) family proteins of Pseudomonas
aeruginosa, a protein encoded by the PA4990 gene (emrE Pae) shows the highest identity …

Bacteria are frequently exposed to cationic antimicrobial peptides (CAMPs) from eukaryotic
hosts (host defence peptides) or from prokaryotic competitors (bacteriocins). However, many …

Antibiotic‐resistant mutants of Pseudomonas aeruginosa were generated using
chloramphenicol and ciprofloxacin as selective agents. These mutants displayed a multidrug …

Antimicrobial peptides have been isolated and characterized from tissues and organisms
representing virtually every kingdom and phylum, ranging from prokaryotes to humans. Yet …

An outer membrane protein of 50 kDa (OprK) was overproduced in a siderophore-deficient
mutant of Pseudomonas aeruginosa capable of growth on iron-deficient minimal medium …

Multiple peptide resistance (MprF) virulence factors control cellular permeability to cationic
antibiotics by aminoacylating inner membrane lipids. It has been shown previously that one …

Certain members of the fluorescent pseudomonads produce and secrete phenazines. These
heterocyclic, redox‐active compounds are toxic to competing organisms, and the cause of …

The human opportunistic pathogen Pseudomonas aeruginosa causes a variety of infections
in immunocompromised hosts and in individuals with cystic fibrosis. A knockout mutation in …

MexAB‐OprM is a multidrug efflux system that contributes to intrinsic and acquired multidrug
resistance in Pseudomonas aeruginosa, the latter as a result of mutational hyperexpression …